Skip to content
Review Open access

Global burden of dengue on healthcare systems: a meta-analysis of healthcare resource utilisation

Oct 2026 · EClinicalMedicine · Vol 100, pp. 104217 · 0 citations · 44 references
Medicine

TL;DR

These findings indicate the considerable burden of dengue driven by HCRU, offering valuable insights for health system preparedness, clinical trial design, and policy planning.

Abstract

Summary Background Dengue poses an increasing health challenge, yet contemporary global healthcare resource utilisation (HCRU) data remain limited. Methods A systematic literature review (SLR) and meta-analysis of studies published 2013–2026 was conducted to estimate hospitalisation rate (HR) and length of stay (LOS) for dengue. Pooled proportions and means were analysed with 95% confidence intervals (CIs) under fixed- and random-effects models globally and by region. Meta-regression models estimated potential sources of heterogeneity. Additionally, sensitivity (excluding sample sizes <100, >50,000, and >50,000 and <100) and subgroup analyses were conducted for disease severity, patient characteristics, and region (PROSPERO# CRD42023480948). Findings Of 341 studies included in the SLR, studies reporting HR (121) and LOS (204) were prioritised for analysis. Global HR among patients with dengue, irrespective of severity, was 36.7% (95% CI 29.0–44.4), under the random-effects model. HR was higher for severe versus non-severe dengue (79.4% [55.9–92.2] versus 26.6% [19.3–35.4]), with versus without warning signs (36.9% [23.3–52.9] versus 17.7% [10.2–28.9]), and in Asia versus Latin America (35.1% [18.0–57.2] versus 29.3% [18.4–43.2]). Global mean LOS among hospitalised patients with dengue, irrespective of severity, was 4.9 days (95% CI 4.6–5.2) under the random-effects model. Severe dengue had longer LOS versus non-severe dengue (6.5 [5.4–7.7] versus 4.6 [4.3–4.9] days), especially for patients with versus without comorbidities (6.1 [5.1–7.2] versus 5.1 [4.3–5.9] days), and in Asia versus Latin America (5.1 [4.8–5.5] versus 4.1 [3.4–4.7] days). Meta-regression showed disease severity was the single significant factor (p < 0.0001) associated with high HR and longer LOS (I2 ≥ 99.8%) among the factors analysed. Interpretation Due to high heterogeneity between studies and interregional differences, pooled estimates should be interpreted with caution. These findings indicate the considerable burden of dengue driven by HCRU, offering valuable insights for health system preparedness, clinical trial design, and policy planning. Funding Novartis Pharma AG.

Read PDF

Similar papers

Oct 2026

Evaluating the Burden of Non-Communicable Diseases in a Tertiary Hospital Setting: A Bangladesh Perspective.

The findings emphasize the imperative for innovative approaches, increased resource allocation and heightened awareness campaigns to effectively address the escalating impact of NCDs on both individuals and communities.

S. B. Proma, M. M. Hasan, A. H. Chowdhury et al. · 0 citations
Review Open access Sep 2026

Association of dengue severity with the serotype of infection: a systematic review and meta-analysis

Summary Background Dengue is a mosquito-borne infection caused by one of four dengue virus serotypes (DENV1-4) that circulates endemically across the tropics and subtropics. To date, there is contrasting evidence on the relationship between the serotype of infection and disease severity. Methods We conducted a systemat...

H. J. Ang, Clare McCormack, C. Donnelly et al. · 0 citations
Open access 2026

Global Assessment of Influenza Disease Burden: A Meta-analysis Examining Mortality, Hospitalization, and Associated Factors in Developed and Developing Countries

Introduction: Influenza, a highly contagious disease, exhibits significant prevalence among both adults and children worldwide. Numerous studies have demonstrated its role in annual deaths and hospitalizations, impacting up to 40% of populations in certain countries. Methods: This research aims to conduct a Meta-analys...

Maham Faheem, R. Sherwani, K. Saleem et al. · 0 citations
Open access Sep 2026

Hospital-level patterns of COVID-19 mortality in Ghana: a retrospective analysis of 2020-2022 routine surveillance data

Introduction: COVID-19 exposed vulnerabilities in health systems, particularly in low- and middle-income countries. Ghana was amongst the hardest hit in West Africa, yet little is known about how outcomes varied across its tiered hospital system. This study aimed to assess the distribution of COVID-19 cases, deaths and...

Gideon Kwarteng Acheampong, W. Quentin, E. Nakua et al. · 0 citations
Review Open access Sep 2026

Hospitalisation costs for malaria and associated factors: a systematic review and meta-analysis

Cost estimates must be stratified by income level and PPP-adjusted to accurately inform global health policies, resource allocation, and economic evaluations to accurately inform global health policies, resource allocation, and economic evaluations.

Pedro Omar Batista Pereira, Mauro José de Deus Morais, G. Z. Laporta et al. · 0 citations
Open access Jan 2026

National and Regional Burden of Hepatitis C in Ethiopia: A Secondary Analysis of the Global Burden of Disease Study 2023

The national and regional burden of hepatitis C infection in Ethiopia between 2019 and 2023 using findings from the Global Burden of Disease Study 2023 showed an increase in prevalence and incidence, and the highest prevalence was observed in the 55+ years age group.

Alemayehu Abate, Melkamnesh Azage · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.